Evidence method
Level · gp.fundamentals.capex_revenue_ratio
16.67% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
NRIX · Nov 30, 2025
Nurix Therapeutics, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001549595-26-000016General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-297.05% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
53.95% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-340.16% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
377.36% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
45.21% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History4 statesHistory building
Period transition
What moved in the state?
- Previous
- 34.34%
- Current
- 16.67%
- Delta
- -17.67%
- Previous
- -726.94%
- Current
- -297.05%
- Delta
- 429.89%
- Previous
- -37.29%
- Current
- 53.95%
- Delta
- 91.24%
- Previous
- -1157.65%
- Current
- -340.16%
- Delta
- 817.49%
- Previous
- 1090.96%
- Current
- 377.36%
- Delta
- -713.60%
- Previous
- 123.79%
- Current
- 45.21%
- Delta
- -78.58%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · NRIX Fundamental State →Has State · Nurix Therapeutics, Inc. →Transitioned To · NRIX Fundamental State →Transitioned To · NRIX CAPEX_INTENSITY_DECREASED →Transitioned To · NRIX CASH_GENERATION_INCREASED →Transitioned To · NRIX GROWTH_INCREASED →Transitioned To · NRIX PROFITABILITY_INCREASED →Transitioned To · NRIX R_AND_D_INTENSITY_DECREASED →Transitioned To · NRIX SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.